Moreover, DZD changed intestinal bacterial communities, inhibited the intestinal TLR4 signaling pathway, restored the expressions of TJ proteins in the gut, and finally relieved HFD-induced NAFLD. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.